subject: CHEBI:75179

object_name: Pathologic Stage III Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:75179

subject_name: Trifluridine

object_name: Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8

tested_intervention: unsure


subject: CHEBI:75179

object_name: Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:75179

object_name: Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:75179

object_name: Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:90879

subject_name: Tipiracil

object_name: Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:90879

object_name: Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:90879

object_name: Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:90879

object_name: Clinical Stage III Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:90879

object_name: Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:90879


subject: CHEBI:90879


subject: CHEBI:90879


subject: CHEBI:90879


subject: CHEBI:90879


subject: UNII:MF497J489P

subject_name: MOSAPRIDE CITRATE

object_name: type 2 diabetes mellitus


subject: UMLS:C0245956

subject_name: Mosapride citrate


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Metastatic non-small cell lung cancer


subject: UNII:M89N0Q7EQR

object_name: lung large cell carcinoma


subject: PR:000001379


subject: PR:000001379


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: DRUGBANK:DB17293

subject_name: Hiltonol

object_name: neurofibromatosis 1


subject: DRUGBANK:DB17293

object_name: neurofibromatosis type 1


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: UNII:7KYP9TKT70


subject: CHEMBL.COMPOUND:CHEMBL5315077

subject_name: TILMANOCEPT

object_name: rheumatoid arthritis

tested_intervention: yes


subject: DRUGBANK:DB16462

object_name: Metastatic castration-resistant prostate cancer


subject: DRUGBANK:DB16462

object_name: Prostatic Cancer, Castration-Resistant


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: Heart Failure, CTCAE


subject: UMLS:C1099192


subject: UMLS:C4079949

object_name: plasma cell myeloma


subject: UMLS:C4079949

object_name: adult lymphoma


subject: UMLS:C4079949

object_name: lymphoma


subject: UMLS:C4079949

object_name: pediatric lymphoma


subject: UMLS:C4079949

object_name: primary central nervous system lymphoma


subject: UMLS:C4079949

object_name: glioblastoma


subject: UMLS:C4079949

object_name: Childhood Glioblastoma


subject: UMLS:C4079949

object_name: adult glioblastoma


subject: CHEBI:179553

subject_name: Hexyl 2-methylpropanoate

object_name: Compulsion


subject: CHEBI:179553

object_name: tic disorder


subject: CHEBI:17334

subject_name: penicillin


subject: CHEBI:17334


subject: CHEBI:17290

subject_name: (S)-3-hydroxybutyric acid

object_name: Schizophrenia and related disorders


subject: CHEBI:17290

object_name: Bipolar and Related Disorders


subject: CHEBI:17290

object_name: Depressed mood


subject: CHEBI:17290

object_name: Manic Episode


subject: CHEBI:17290

object_name: psychosis


subject: CHEBI:17290

object_name: Nonorganic psychosis


subject: CHEBI:17290

object_name: Psychosis, CTCAE


subject: CHEBI:37054


subject: CHEBI:37054


subject: CHEBI:37054


subject: CHEBI:37054


subject: CHEBI:37054


subject: CHEBI:37054


subject: CHEBI:37054


subject: UMLS:C0106006


subject: UMLS:C0106006


subject: UMLS:C0106006


subject: UMLS:C0106006


subject: UMLS:C0106006


subject: UMLS:C0106006


subject: UMLS:C0106006


subject: CHEBI:15365

subject_name: Aspirin

object_name: migraine


subject: UMLS:C0499161

subject_name: Not otherwise classified, antineoplastic drugs

object_name: Extrapulmonary Small Cell Carcinoma


subject: UMLS:C0499161

object_name: esophageal squamous cell carcinoma


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]


subject: UNII:R318PGH5VP

subject_name: Danirixin

object_name: respiratory syncytial virus infectious disease


subject: CHEBI:29321

subject_name: sodium nitroprusside

object_name: acute respiratory distress syndrome


subject: CHEBI:29321

object_name: acute lung injury


subject: CHEBI:29321

object_name: Hypoxemia


subject: CHEBI:29321

object_name: Hypoxia, CTCAE


subject: CHEBI:29321

object_name: adult acute respiratory distress syndrome


subject: CHEBI:29321

object_name: respiratory failure


subject: CHEBI:29321

object_name: Respiratory Failure, CTCAE


subject: UNII:EAO03PE1TC

subject_name: Sodium nitroprusside hydrate


subject: UNII:EAO03PE1TC


subject: UNII:EAO03PE1TC


subject: UNII:EAO03PE1TC


subject: UNII:EAO03PE1TC


subject: UNII:EAO03PE1TC


subject: UNII:EAO03PE1TC


subject: PUBCHEM.COMPOUND:129696905


subject: PUBCHEM.COMPOUND:129696905


subject: PUBCHEM.COMPOUND:129696905


subject: PUBCHEM.COMPOUND:129696905


subject: PUBCHEM.COMPOUND:129696905


subject: PUBCHEM.COMPOUND:129696905


subject: PUBCHEM.COMPOUND:129696905


subject: CHEBI:41948

subject_name: Eflornithine

object_name: Pseudofolliculitis barbae


subject: CHEBI:57586

subject_name: biotinate

object_name: Ingrown nail


subject: CHEBI:15956

subject_name: Biotin


subject: CHEBI:9398

subject_name: Tamsulosin

object_name: Inguinal hernia


subject: CHEBI:6801

subject_name: Metformin

object_name: lung large cell carcinoma


subject: CHEBI:6801

object_name: squamous cell lung carcinoma


subject: CHEBI:6801

object_name: adenosquamous lung carcinoma


subject: CHEBI:6801

object_name: lung adenocarcinoma in situ


subject: CHEBI:6801

object_name: minimally invasive lung adenocarcinoma


subject: PR:000001151

subject_name: Toll-like receptor 1

object_name: rectal carcinoma


subject: PR:000001151

object_name: rectal cancer


subject: PUBCHEM.COMPOUND:5311449

object_name: ulcerative colitis


subject: PUBCHEM.COMPOUND:5311449

object_name: inflammatory bowel disease 1


subject: PUBCHEM.COMPOUND:5311449

object_name: inflammatory bowel disease


subject: CHEBI:65173

subject_name: Iloperidone

object_name: Hepatic impairment


subject: PUBCHEM.COMPOUND:152165

object_name: osteoarthritis, hip


subject: CHEBI:47381

subject_name: Diclofenac


subject: CHEBI:71954

subject_name: Buparlisib

object_name: HER2 positive breast carcinoma


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: autoimmune thrombocytopenia


subject: CHEBI:5801

object_name: thrombocytopenia due to immune destruction


subject: CHEBI:5801

object_name: autoimmune thrombocytopenic purpura


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Hemorrhoids, CTCAE 3.0


subject: CHEBI:3215

object_name: Hemorrhoids, CTCAE 5.0


subject: UMLS:C5856414

subject_name: Copper Cu 64 EB-ss-CPT

object_name: colorectal cancer


subject: UMLS:C5856414

object_name: colorectal carcinoma


subject: UMLS:C5856414

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5856417

subject_name: Gallium Ga 68 EB-ss-CPT


subject: UMLS:C5856417


subject: UMLS:C5856417


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: triple-negative breast carcinoma


subject: CHEBI:79699

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:O3MNS8782H

object_name: Solid Neoplasm


subject: UMLS:C3827144


subject: PR:000022780

subject_name: phosphoglucosamine mutase

object_name: Catheter related infection


subject: UniProtKB:P31120

subject_name: GLMM_ECOLI Phosphoglucosamine mutase (sprot)


subject: CHEBI:94646

subject_name: Flupirtine

object_name: Central neuronal chromatolysis


subject: UMLS:C5417850

subject_name: Anti-EGFR/CD16A Bispecific Antibody AFM24

object_name: metastatic neoplasm


subject: UMLS:C5417850

object_name: Embolism, Tumor


subject: UMLS:C5417850

object_name: Neoplasm Metastasis


subject: UMLS:C5417850

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5417850

object_name: non-small cell lung carcinoma


subject: UMLS:C5417850

object_name: Refractory Neoplasm


subject: UMLS:C5417850

object_name: colorectal neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4650287


subject: CHEMBL.COMPOUND:CHEMBL4650287


subject: CHEMBL.COMPOUND:CHEMBL4650287


subject: CHEBI:90748

object_name: pancreatic neoplasm


subject: UMLS:C2347328

subject_name: sirolimus protein-bound particles

object_name: endometrial cancer


subject: UMLS:C2347328

object_name: uterine corpus cancer


subject: UMLS:C2347328

object_name: Recurrent Endometrial Cancer


subject: UMLS:C2347328

object_name: endometrioid tumor


subject: CHEBI:2453

subject_name: Acyclovir

object_name: multiple sclerosis


subject: CHEBI:4464

subject_name: Dexchlorpheniramine


subject: CHEBI:46195

subject_name: Acetaminophen


subject: CHEBI:8378

subject_name: Prednisolone


subject: UNII:884KT10YB7

subject_name: (Z)-ranitidine


subject: CHEBI:8776

subject_name: ranitidine


subject: UNII:QQA9MLH692

subject_name: Tafasitamab

object_name: primary mediastinal large B-cell lymphoma


subject: UMLS:C2987409


subject: UNII:5792C4VMFZ

subject_name: Calcium palmitate

object_name: inherited lipid metabolism disorder


subject: UNII:5792C4VMFZ

object_name: Dyslipidemia


subject: CHEBI:15756

subject_name: Palmitic Acid


subject: CHEBI:15756


subject: CHEBI:28842

subject_name: Stearic acid


subject: CHEBI:28842


subject: CHEBI:190296

subject_name: calcium stearate


subject: CHEBI:190296


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: Adult Soft Tissue Sarcoma


subject: UNII:PVI5M0M1GW

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UNII:PVI5M0M1GW

object_name: soft tissue sarcoma


subject: UNII:PVI5M0M1GW

object_name: cervical carcinoma


subject: UNII:PVI5M0M1GW

object_name: KRAS mutation-related tumors


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: UNII:3A58010674

subject_name: Pegfilgrastim

object_name: Childhood Soft Tissue Sarcoma


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674

object_name: cervical cancer


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: venous thromboembolism


subject: UNII:L500PR95QA

object_name: thrombophilia due to thrombin defect


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:6909


subject: CHEBI:28918

subject_name: Epinephrine

object_name: Surgical Wound Infection


subject: CHEBI:28918


subject: CHEBI:28918


subject: UMLS:C5767265

subject_name: Elucirem

object_name: Myocardial fibrosis


subject: UNII:S276568KOY

subject_name: Gadopiclenol


subject: CHEBI:93109

subject_name: Semaxanib

object_name: Neck Carcinoma


subject: CHEBI:93109

object_name: head and neck neoplasm


subject: CHEBI:93109

object_name: head and neck cancer


subject: CHEBI:93109

object_name: cancer of unknown primary site


subject: CHEBI:91083

subject_name: Romiplostim


subject: CHEBI:91083


subject: CHEBI:91083


subject: CHEBI:91083


subject: UMLS:C0445115

subject_name: Normal saline

object_name: rheumatoid arthritis


subject: UNII:16VY3TM7ZO

subject_name: Antineoplaston A10

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UNII:16VY3TM7ZO

object_name: stage IV pancreatic cancer


subject: UNII:16VY3TM7ZO

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UMLS:C4721487

subject_name: ATENGENAL


subject: UMLS:C4721487


subject: UMLS:C4721487


subject: UMLS:C4721495

subject_name: Astugenal


subject: UMLS:C4721495


subject: UMLS:C4721495


subject: UMLS:C5556424

subject_name: Lumrotatug

object_name: IgA Nephropathy


subject: CHEBI:72690

subject_name: Pomalidomide

object_name: myelofibrosis with myeloid metaplasia


subject: CHEBI:72690

object_name: Myeloid Metaplasia


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:9150

subject_name: Simvastatin

object_name: celiac disease


subject: CHEBI:119486

subject_name: Efavirenz

object_name: hyperlipidemia


subject: CHEBI:119486

object_name: hyperlipoproteinemia


subject: CHEBI:119486

object_name: Hyperlipidemia, CTCAE


subject: CHEBI:119486

object_name: Serum lipids high (finding)


subject: UMLS:C0684259

subject_name: Humatrope

object_name: osteogenesis imperfecta


subject: UMLS:C0812735

subject_name: INJECTION FLUCONAZOLE, 200 MG ADMINISTERED

object_name: Food-Drug Interactions


subject: CHEBI:46081

subject_name: Fluconazole


subject: CHEBI:7772

subject_name: omeprazole


subject: CHEBI:77260

subject_name: Omeprazole


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: UNII:D6OMY2L0WA

subject_name: Epcoritamab

object_name: Richter syndrome


subject: UMLS:C5206892

subject_name: epcoritamab


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:230905

subject_name: Ribociclib

object_name: metastatic prostate carcinoma


subject: CHEBI:230905

object_name: castration-resistant prostate carcinoma


subject: CHEBI:230905

object_name: Prostate Carcinoma Metastatic in the Bone


subject: CHEBI:230905

object_name: Stage IV Prostate Cancer AJCC v7


subject: UNII:C8ADC441ME

subject_name: Ivabradine

object_name: Family history of ischemic heart disease


subject: UMLS:C5204487

subject_name: PI3K/mTOR Kinase Inhibitor WXFL10030390

object_name: PIK3CA mutation-related tumors


subject: CHEBI:93274

subject_name: Fluvoxamine


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Plasma cell tumor, malignant


subject: CHEBI:45716

object_name: plasma cell neoplasm


subject: CHEBI:9349

subject_name: Dimethyl sulfone

object_name: Joint hypermobility


subject: CHEBI:9349

object_name: Ligament injury


subject: CHEBI:9349

object_name: Tendon rupture


subject: CHEBI:9349

object_name: Tendon Injuries


subject: UMLS:C1166209

subject_name: Viscum album preparation

object_name: pancreatic neoplasm


subject: UMLS:C1166209

object_name: exocrine pancreatic carcinoma


subject: UMLS:C1166209

object_name: malignant pancreatic neoplasm


subject: UMLS:C0063891

subject_name: Iscador


subject: UMLS:C0063891


subject: UMLS:C0063891


subject: CHEBI:70715

subject_name: Zinforo

object_name: Complicated skin and soft tissue infection


subject: CHEBI:70715

object_name: Community-Acquired Pneumonia


subject: UMLS:C5828406


subject: UMLS:C5828406


subject: CHEBI:7820

subject_name: Oxandrolone

object_name: Fanconi anemia


subject: CHEBI:7820

object_name: Fanconi anemia complementation group A


subject: CHEBI:233324

subject_name: Darovasertib

object_name: ocular melanoma


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: IgA Nephropathy


subject: CHEBI:94534

subject_name: olanzapine

object_name: substance withdrawal syndrome


subject: UMLS:C3896931

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UMLS:C3896931

object_name: Ph-positive acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:172973390

subject_name: Ceftolozane-tazobactam

object_name: Pseudomonas aeruginosa infection


subject: PUBCHEM.COMPOUND:172973390

object_name: Pseudomonas infection


subject: UMLS:C3656593

subject_name: ceftolozane / tazobactam


subject: UMLS:C3656593


subject: PUBCHEM.COMPOUND:56841986

subject_name: Plasmalyte A

object_name: Delayed Graft Function


subject: PUBCHEM.COMPOUND:56841986

object_name: Disorder of transplanted kidney


subject: PUBCHEM.COMPOUND:56841986

object_name: end stage renal failure


subject: PUBCHEM.COMPOUND:56841986

object_name: Chronic uremia


subject: CHEBI:73024

subject_name: O-acetylcarnitine

object_name: prostate carcinoma


subject: CHEBI:73024

object_name: prostate cancer


subject: CHEBI:73024

object_name: ovarian cancer


subject: CHEBI:73024

object_name: ovarian neoplasm


subject: CHEBI:73024

object_name: ovarian carcinoma


subject: CHEBI:57589

subject_name: Acetylcarnitine


subject: CHEBI:57589


subject: CHEBI:57589


subject: CHEBI:57589


subject: CHEBI:57589


subject: UMLS:C1572570

subject_name: PEANUT preparation

object_name: peanut allergy


subject: UMLS:C1696729

subject_name: peanut - non-drug agent


subject: UNII:3A58010674

subject_name: Pegfilgrastim

object_name: Neck Carcinoma


subject: UNII:3A58010674

object_name: head and neck neoplasm


subject: CHEBI:15366

subject_name: Acetic acid

object_name: mitral valve insufficiency


subject: CHEBI:42944

subject_name: Galantamine

object_name: cocaine dependence


subject: CHEBI:74705

subject_name: Met-Leu

object_name: rheumatoid arthritis


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:6504

object_name: Machado-Joseph disease


subject: CHEBI:188074

object_name: Reperfusion Injury


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: CHEBI:4495

subject_name: Diazoxide

object_name: Hypothalamic obesity


subject: CHEBI:6801

subject_name: Metformin


subject: UMLS:C5540858

subject_name: bamlanivimab and etesevimab drug combination


subject: UMLS:C5703650

subject_name: Mpox Vaccine

object_name: monkeypox


subject: CHEMBL.COMPOUND:CHEMBL4297686

subject_name: IZOKIBEP

object_name: psoriatic arthritis


subject: UMLS:C5421163

subject_name: Izokibep


subject: CHEBI:27732

subject_name: Caffeine

object_name: Blood Pressure Finding


subject: CHEBI:27732

object_name: Systemic arterial pressure


subject: CHEBI:27732

object_name: 3-lead electrocardiogram rhythm strip: heart rate


subject: UMLS:C0873002

subject_name: cayenne extract

object_name: mood (physical finding)


subject: UMLS:C0873002


subject: UMLS:C0873002


subject: UMLS:C0873002


subject: UMLS:C5574818

subject_name: Cayenne (substance)


subject: UMLS:C5574818


subject: UMLS:C5574818


subject: UMLS:C5574818


subject: UMLS:C2927565

subject_name: cayenne pepper allergenic extract


subject: UMLS:C2927565


subject: UMLS:C2927565


subject: UMLS:C2927565


subject: DRUGBANK:DB10897

subject_name: Capsicum


subject: DRUGBANK:DB10897


subject: DRUGBANK:DB10897


subject: DRUGBANK:DB10897


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Instrumental delivery (finding)


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: berylliosis


subject: UNII:B72HH48FLU

object_name: Beryllium Disease


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:22652

object_name: clear cell renal carcinoma


subject: CHEBI:22652

object_name: Unresectable Renal Cell Carcinoma


subject: CHEBI:22652

object_name: Clear-cell metastatic renal cell carcinoma


subject: CHEBI:22652

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: CHEBI:22652

object_name: Stage III Renal Cell Cancer AJCC v8


subject: CHEBI:73609

subject_name: Met-Ala-Asp

object_name: Cognitive impairment


subject: MESH:C110804

subject_name: mycophenolic adenine dinucleotide


subject: UNII:7DT29059VX

object_name: endometrial cancer


subject: UNII:7DT29059VX

object_name: uterine corpus cancer


subject: UNII:7DT29059VX

object_name: endometrial carcinoma


subject: UMLS:C2981846


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: Hyperthermia


subject: CHEBI:6887

object_name: Fever


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: metastatic prostate carcinoma


subject: UNII:1C6V77QF41

object_name: Localized Prostate Carcinoma


subject: UNII:1C6V77QF41

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: UNII:8202AY8I7H

subject_name: Eptinezumab

object_name: Transformed migraine


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: rhabdomyosarcoma


subject: UNII:2S9ZZM9Q9V

object_name: Childhood Rhabdomyosarcoma


subject: CHEBI:50223

subject_name: Dexrazoxane

object_name: Adult Rhabdomyosarcoma


subject: CHEBI:50223


subject: CHEBI:50223


subject: CHEBI:50223

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: PUBCHEM.COMPOUND:16760419

subject_name: Etoposide phosphate


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: PUBCHEM.COMPOUND:15556483

subject_name: METHIONINE C 11


subject: PUBCHEM.COMPOUND:15556483


subject: PUBCHEM.COMPOUND:15556483


subject: PUBCHEM.COMPOUND:15556483


subject: UNII:ED857BWP29

subject_name: Methionine C-11


subject: UNII:ED857BWP29


subject: UNII:ED857BWP29


subject: UNII:ED857BWP29


subject: UMLS:C0252667


subject: UMLS:C0252667


subject: UMLS:C0252667


subject: UMLS:C0252667


subject: UMLS:C4547233

object_name: kidney failure


subject: CHEBI:16919

subject_name: Creatine

object_name: homocystinuria


subject: MESH:C538828

object_name: Solid Neoplasm


subject: CHEBI:9241

subject_name: Spironolactone

object_name: Congenital Disorders


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: CHEBI:63925

subject_name: PhXa 85

object_name: eye disorder


subject: CHEBI:60787

subject_name: TIMOLOL


subject: UMLS:C2984033

object_name: Adult Acute Lymphoblastic Leukemia in Remission


subject: UMLS:C2984033

object_name: Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UMLS:C2984033

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UMLS:C2984033

object_name: Myelodysplasia


subject: UMLS:C2984033

object_name: Acute myeloid leukemia in remission


subject: UMLS:C2984033

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C2984033

object_name: myeloproliferative neoplasm


subject: CHEBI:47458

subject_name: Saracatinib

object_name: Alzheimer disease


subject: CHEBI:5494

subject_name: ritropirronium bromide

object_name: Hyperhidrosis, CTCAE


subject: CHEBI:30772

subject_name: Butyric Acid


subject: CHEBI:30772

object_name: Hyperhidrosis


subject: UNII:4FR53SIF3A

subject_name: Blinatumomab

object_name: complete trisomy 21


subject: UNII:4FR53SIF3A

object_name: Down syndrome


subject: UNII:T9FVH03HMZ

subject_name: Calaspargase pegol


subject: UNII:T9FVH03HMZ


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:31822

subject_name: MERCAPTOPURINE


subject: CHEBI:31822


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:7D96IR0PPM

subject_name: Pegaspargase


subject: UNII:7D96IR0PPM


subject: UNII:Y8KTZ6Y35U

subject_name: PEGCRISANTASPASE


subject: UNII:Y8KTZ6Y35U


subject: UNII:Y8KTZ6Y35U

object_name: Recurrent B Acute Lymphoblastic Leukemia


subject: UMLS:C3640058

subject_name: Asparec


subject: UMLS:C3640058


subject: UMLS:C3640058


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:71219

subject_name: Pazopanib

object_name: lymphedema


subject: CHEBI:71219

object_name: Lymphedema, CTCAE


subject: CHEBI:64312

subject_name: Memantine

object_name: body dysmorphic disorder


subject: CHEBI:64312

object_name: bulimia nervosa


subject: UMLS:C1541478

subject_name: Astuprotimut-R

object_name: non-small cell lung carcinoma


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Locally Advanced Malignant Neoplasm


subject: CHEBI:90881

subject_name: Camptosar

object_name: adult oligodendroglioma


subject: CHEBI:90881

object_name: oligodendroglioma


subject: CHEBI:90881

object_name: Childhood Astrocytoma


subject: CHEBI:90881

object_name: astrocytic tumor


subject: CHEBI:90881

object_name: astrocytoma


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: sickle cell disease


subject: CHEBI:17460

subject_name: Thioctamide


subject: CHEBI:16494

subject_name: thioctic acid


subject: CHEBI:73024

subject_name: O-acetylcarnitine


subject: CHEBI:57589

subject_name: Acetylcarnitine


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: complex regional pain syndrome type 1


subject: UMLS:C5854459

subject_name: Chk1 Inhibitor BBI-355

object_name: Metastatic malignant neoplasm to pancreas


subject: UMLS:C5854459

object_name: small cell lung carcinoma


subject: UMLS:C5854459

object_name: High Grade Endometrial Carcinoma


subject: UMLS:C5854459

object_name: cervical squamous cell carcinoma


subject: UMLS:C5854459

object_name: estrogen-receptor positive breast cancer


subject: UMLS:C5854459

object_name: leiomyosarcoma


subject: UMLS:C5962732

subject_name: RNR Inhibitor BBI-825


subject: UMLS:C5962732


subject: UMLS:C5962732


subject: UMLS:C5962732


subject: UMLS:C5962732


subject: UMLS:C5962732


subject: CHEBI:114785

subject_name: Erlotinib


subject: CHEBI:114785


subject: CHEBI:114785


subject: UNII:4B93MGE4AL

subject_name: Futibatinib


subject: UNII:4B93MGE4AL


subject: UNII:4B93MGE4AL


subject: UNII:4B93MGE4AL


subject: UNII:4B93MGE4AL


subject: UNII:4B93MGE4AL


subject: UMLS:C0920324

subject_name: Homeopathic Remedies

object_name: female infertility


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: thymic epithelial neoplasm


subject: MESH:C496822

subject_name: xuezhikang

object_name: hyperlipidemia


subject: MESH:C496822

object_name: hyperlipoproteinemia


subject: MESH:C496822

object_name: Hyperlipidemia, CTCAE


subject: MESH:C496822

object_name: Serum lipids high (finding)


subject: CHEBI:231891


subject: CHEBI:231891


subject: CHEBI:231891


subject: CHEBI:231891


subject: CHEBI:23359

subject_name: colchicine

object_name: Periprocedural myocardial infarction


subject: CHEBI:17026

subject_name: Progesterone

object_name: endometrial cancer


subject: CHEBI:17026

object_name: uterine corpus cancer


subject: CHEBI:17026

object_name: endometrial carcinoma


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: UMLS:C2757070


subject: UMLS:C2757070


subject: UMLS:C2757070

object_name: Hyperplasia of the endometrium


subject: UMLS:C5784740

subject_name: EGFR Mutant-selective Inhibitor NX-019

object_name: EGFR mutation-related tumors


subject: CHEBI:8427

subject_name: Probucol

object_name: transient ischemic attack


subject: CHEBI:8427

object_name: punctate palmoplantar keratoderma type III


subject: UMLS:C3485411

subject_name: Combivent Respimat

object_name: COPD, severe early onset


subject: UMLS:C3485411

object_name: chronic obstructive pulmonary disease


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: glioma


subject: CHEBI:66919

object_name: malignant glioma


subject: UMLS:C5238374

subject_name: Doxorubicin Prodrug/Prodrug-activating Biomaterial SQ3370

object_name: cancer


subject: UMLS:C5238374

object_name: neoplasm


subject: CHEBI:52993

subject_name: Lormetazepam

object_name: Convulsions


subject: CHEBI:6539

subject_name: Lorazepam


subject: UNII:1IJV77EI07

subject_name: Tepotinib

object_name: Hepatic impairment


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Complication of hemodialysis


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:134716

subject_name: Brexpiprazole

object_name: Irritability


subject: CHEBI:134716

object_name: Irritability, CTCAE


subject: CHEBI:85974

subject_name: edoxaban tosylate hydrate

object_name: Complication of catheter


subject: PUBCHEM.COMPOUND:11635624

subject_name: Edoxaban


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Advanced Soft Tissue Sarcoma


subject: CHEBI:9168

subject_name: Sirolimus


subject: PR:000007515

subject_name: four and a half LIM domains protein 5

object_name: colorectal cancer


subject: PR:000007515

object_name: colorectal carcinoma


subject: PR:000007515

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PR:000014683


subject: PR:000014683


subject: PR:000014683


subject: PR:000023516

subject_name: pyruvate formate-lyase 1-activating enzyme


subject: PR:000023516


subject: PR:000023516


subject: UniProtKB:P0A9N4

subject_name: PFLA_ECOLI Pyruvate formate-lyase 1-activating enzyme (sprot)


subject: UniProtKB:P0A9N4


subject: UniProtKB:P0A9N4


subject: UMLS:C4510275

subject_name: Sulfur hexafluoride lipid microsphere

object_name: liver carcinoma


subject: UMLS:C3852764

subject_name: PEG-rhG-CSF

object_name: leukopenia


subject: UMLS:C3852764

object_name: neutropenia


subject: CHEBI:28918

subject_name: Epinephrine

object_name: Childhood Breast Carcinoma


subject: CHEBI:28918

object_name: breast carcinoma


subject: CHEBI:28918

object_name: breast cancer


subject: CHEBI:149504

object_name: diabetic macular edema


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6904

subject_name: Metoprolol

object_name: malaria


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: chronic gastritis


subject: UNII:532PWU9738

object_name: Clostridium difficile colitis


subject: UNII:532PWU9738

object_name: clostridium difficile infection


subject: CHEBI:231594

subject_name: Norgestrel

object_name: tuberculosis


subject: UMLS:C0001645

subject_name: Adrenergic beta-Antagonists

object_name: catecholaminergic polymorphic ventricular tachycardia


subject: UMLS:C0001645

object_name: Effort-induced polymorphic ventricular tachycardia


subject: CHEBI:75984

subject_name: Flecainide


subject: CHEBI:75984


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: intestinal infectious disease


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C3713880


subject: UMLS:C5666886

subject_name: Microbiome SER-155

object_name: enterocolitis


subject: UMLS:C5666886

object_name: Enterocolitis, CTCAE


subject: UMLS:C5666886

object_name: diarrhea


subject: UMLS:C5666886

object_name: rectal discharge diarrhea (physical finding)


subject: UMLS:C5666886

object_name: Diarrhea, CTCAE


subject: UMLS:C3248394

subject_name: Injection, ipilimumab, 1 mg administered

object_name: pancreatic neoplasm


subject: UMLS:C3248394

object_name: exocrine pancreatic carcinoma


subject: UMLS:C3248394

object_name: malignant pancreatic neoplasm


subject: UMLS:C5203457

subject_name: Ipilimumab Liquid Injection


subject: UMLS:C5203457


subject: UMLS:C5203457


subject: UMLS:C5238967

object_name: EXCESS LMW-DNA


subject: UMLS:C5455243

subject_name: Camcevi

object_name: prostate cancer


subject: UMLS:C5455243

object_name: prostate neoplasm


subject: UMLS:C3485429

subject_name: Probiotic Formula

object_name: Compulsion


subject: UNII:26X6QU3JUB

subject_name: BIFIDOBACTERIUM LONGUM R0175


subject: CHEBI:8378

subject_name: Prednisolone

object_name: Articular cartilage disorder of knee


subject: CHEBI:15927

subject_name: Nicotinamide riboside

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:15927

object_name: heart valve disorder


subject: GTOPDB:13085

subject_name: adebrelimab

object_name: esophageal small cell neuroendocrine carcinoma


subject: UNII:1XBY50W1OX

subject_name: ADEBRELIMAB


subject: UMLS:C4725109


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:16899

subject_name: Mannitol

object_name: Subarachnoid Hemorrhage, Aneurysmal


subject: CHEBI:135918

subject_name: Tucidinostat

object_name: colon adenocarcinoma


subject: GTOPDB:9592

subject_name: tislelizumab


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: CHEBI:9605

subject_name: Tirofiban

object_name: brain aneurysm


subject: UMLS:C1831890

object_name: cancer


subject: UMLS:C1831890

object_name: adult lymphoma


subject: UMLS:C1831890

object_name: lymphoma


subject: UMLS:C1831890

object_name: pediatric lymphoma


subject: CHEBI:9014

subject_name: Salsalate

object_name: Alzheimer disease type 1


subject: CHEBI:9014

object_name: Alzheimer disease


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: malignant mesothelioma


subject: UMLS:C0378942

object_name: Sicca Syndrome


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: polycythemia


subject: PUBCHEM.COMPOUND:92043599

object_name: Abnormal erythrocyte production


subject: UMLS:C0376541

subject_name: Recombinant Erythropoietin


subject: UMLS:C0376541


subject: UNII:C2M78A9V6Z

object_name: ulcerative colitis


subject: UNII:C2M78A9V6Z

object_name: inflammatory bowel disease 1


subject: CHEBI:27605

subject_name: Psicose

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:27605

object_name: obesity


subject: CHEBI:27605

object_name: Obesity, CTCAE


subject: CHEBI:85974

subject_name: edoxaban tosylate hydrate

object_name: Fragility


subject: PUBCHEM.COMPOUND:11635624

subject_name: Edoxaban


subject: CHEBI:4875

subject_name: Etanercept

object_name: chronic idiopathic urticaria


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: UMLS:C0338133

subject_name: Gemzar

object_name: stage IV pancreatic cancer


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:63791

object_name: pancreatic ductal adenocarcinoma


subject: UNII:0DE9724IHC

subject_name: Protamine

object_name: Allergy to protamine


subject: UNII:0DE9724IHC

object_name: Protamine adverse reaction


subject: UMLS:C0033603

subject_name: protamines


subject: UMLS:C0033603


subject: UniProtKB:P15340

subject_name: HSP1_CHICK Sperm histone (sprot)


subject: UniProtKB:P15340


subject: UNII:85X09V2GSO

subject_name: Lasofoxifene tartrate

object_name: Postmenopausal symptoms


subject: CHEMBL.COMPOUND:CHEMBL5315115

subject_name: LASOFOXIFENE TARTRATE


subject: UMLS:C2825304

subject_name: Lasofoxifene Tartrate


subject: PUBCHEM.COMPOUND:11332179

subject_name: pasireotide

object_name: congenital isolated hyperinsulinism


subject: MESH:C550870

subject_name: Dandshen

object_name: acute kidney failure


subject: MESH:C550870

object_name: Acute Kidney Injury, CTCAE


subject: MESH:C550870

object_name: nephrotic syndrome


subject: MESH:C550870

object_name: Nephrotic Syndrome, CTCAE


subject: MESH:C550870

object_name: kidney disorder


subject: CHEBI:3219

subject_name: Bupropion

object_name: head and neck squamous cell carcinoma


subject: CHEBI:3219

object_name: laryngeal squamous cell carcinoma


subject: CHEBI:3219

object_name: oral cavity squamous cell carcinoma


subject: CHEBI:3219

object_name: oropharynx squamous cell carcinoma


subject: CHEBI:3219

object_name: hypopharynx squamous cell carcinoma


subject: CHEBI:3219

object_name: Smoker


subject: CHEBI:3219

object_name: Current smoker (e.g., cigarette, cigar, pipe, e-cigarette or marijuana)


subject: CHEBI:3219

object_name: nasopharyngeal carcinoma


subject: CHEBI:3219

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: CHEBI:8768

subject_name: Rabeprazole

object_name: Non-erosive gastro-esophageal reflux disease


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: graft versus host disease


subject: CHEBI:34574


subject: CHEBI:42085

subject_name: 7,8-Diamino-Nonanoic Acid


subject: CHEBI:16026

subject_name: 2,6-Diaminopimelic Acid


subject: CHEBI:2247

subject_name: 7,8-diaminononanoic acid


subject: UMLS:C0718247

subject_name: Active brand of pseudoephedrine-triprolidine

object_name: Stress


subject: UMLS:C0718247

object_name: Physiological Stress


subject: CHEBI:521033

subject_name: Dutasteride

object_name: Kennedy disease


subject: CHEBI:291342

subject_name: Desloratadine

object_name: Pruritus, CTCAE


subject: CHEBI:291342

object_name: Pruritus


subject: CHEBI:92511

subject_name: Ketotifen


subject: CHEBI:92511


subject: PUBCHEM.COMPOUND:74328238

subject_name: Sotagliflozin

object_name: cardiac sarcoidosis


subject: MESH:C000722901

object_name: molluscum contagiosum


subject: UNII:06IVK87M04

subject_name: Zelavespib

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C4310558


subject: UMLS:C3641122

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: UNII:X7REK61AIS

object_name: ulcerative colitis


subject: UNII:X7REK61AIS

object_name: inflammatory bowel disease 1


subject: UMLS:C4045909


subject: UMLS:C4045909


subject: UMLS:C3540798

subject_name: Food allergenic extracts

object_name: Solid Neoplasm


subject: CHEBI:28971

subject_name: Ampicillin

object_name: bacterial pneumonia


subject: PUBCHEM.COMPOUND:5316

subject_name: Sulbactam


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Presenile dementia


subject: CHEBI:25681

object_name: dementia


subject: PUBCHEM.COMPOUND:49865963

subject_name: TRABECTEDIN

object_name: pancreatic neoplasm


subject: PUBCHEM.COMPOUND:49865963

object_name: exocrine pancreatic carcinoma


subject: PUBCHEM.COMPOUND:49865963

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:3199

subject_name: ecteinascidin 743


subject: PUBCHEM.COMPOUND:3199


subject: PUBCHEM.COMPOUND:3199


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: myocardial infarction


subject: CHEBI:60648

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:60648

object_name: Myocardial Infarction by ECG Finding


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: CHEBI:76016

subject_name: Vortioxetine

object_name: Post-Operative Pain


subject: UMLS:C3273001

object_name: prostate cancer


subject: UMLS:C3273001

object_name: prostate neoplasm


subject: PUBCHEM.COMPOUND:74412639

subject_name: Solithromycin


subject: CHEBI:3441

subject_name: Carvedilol

object_name: digestive system disorder


subject: CHEBI:3441

object_name: Esophageal ulcer caused by aspirin


subject: CHEBI:3441

object_name: myocardial ischemia


subject: UMLS:C0499161

subject_name: Not otherwise classified, antineoplastic drugs

object_name: HLA Class I Histocompatibility Antigen, A-0201 Alpha Chain Positive


subject: UMLS:C0499161

object_name: HLA-A*0201 Positive Cells Present


subject: UMLS:C0499161

object_name: cancer


subject: UMLS:C0499161

object_name: neoplasm


subject: PUBCHEM.COMPOUND:53378893

subject_name: Kinase inhibitor


subject: PUBCHEM.COMPOUND:53378893


subject: UMLS:C0003250

subject_name: Monoclonal Antibodies


subject: UMLS:C0003250


subject: UMLS:C0003250


subject: UMLS:C0003250


subject: UMLS:C5203232

subject_name: Monoclonal Antibody [EPC]


subject: UMLS:C5203232


subject: UMLS:C5203232


subject: UMLS:C5203232


subject: PUBCHEM.COMPOUND:164593978

object_name: renal cell adenocarcinoma


subject: PUBCHEM.COMPOUND:164593978

object_name: renal cell carcinoma


subject: UMLS:C5555738

object_name: diffuse large B-cell lymphoma


subject: UMLS:C5555738

object_name: adult acute myeloid leukemia


subject: UMLS:C5555738

object_name: childhood acute myeloid leukemia


subject: UMLS:C5555738

object_name: acute myeloid leukemia


subject: CHEBI:3219

subject_name: Bupropion

object_name: cannabis abuse


subject: CHEBI:35690

object_name: non-small cell lung carcinoma


subject: CHEBI:64312

subject_name: Memantine

object_name: neurodegenerative disease


subject: PUBCHEM.COMPOUND:146195299

subject_name: Golcadomide

object_name: Refractory Aggressive B-Cell Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:146195299

object_name: Recurrent Aggressive B-Cell Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:146195299

object_name: Refractory Transformed Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:146195299

object_name: Non-Hodgkin's lymphoma transformed recurrent


subject: PUBCHEM.COMPOUND:146195299

object_name: Refractory ALK-Positive Large B-Cell Lymphoma


subject: PUBCHEM.COMPOUND:146195299

object_name: Refractory Intravascular Large B-Cell Lymphoma


subject: PUBCHEM.COMPOUND:146195299

object_name: Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type


subject: PUBCHEM.COMPOUND:146195299

object_name: Large B-cell lymphoma with IRF4 rearrangement


subject: PUBCHEM.COMPOUND:146195299

object_name: Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma


subject: PUBCHEM.COMPOUND:146195299

object_name: Refractory High Grade B-Cell Lymphoma, Not Otherwise Specified


subject: PUBCHEM.COMPOUND:146195299

object_name: Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: PUBCHEM.COMPOUND:146195299

object_name: Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type


subject: PUBCHEM.COMPOUND:146195299

object_name: Refractory Grade 3b Follicular Lymphoma


subject: PUBCHEM.COMPOUND:146195299

object_name: Primary mediastinal large B-cell lymphoma recurrent


subject: PUBCHEM.COMPOUND:146195299

object_name: Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified


subject: PUBCHEM.COMPOUND:146195299

object_name: Refractory Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type


subject: PUBCHEM.COMPOUND:146195299

object_name: Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: PUBCHEM.COMPOUND:146195299

object_name: Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: PUBCHEM.COMPOUND:146195299

object_name: Recurrent ALK-Positive Large B-Cell Lymphoma


subject: PUBCHEM.COMPOUND:146195299

object_name: Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type


subject: PUBCHEM.COMPOUND:146195299

object_name: Recurrent Intravascular Large B-Cell Lymphoma


subject: PUBCHEM.COMPOUND:146195299

object_name: Recurrent EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: PUBCHEM.COMPOUND:146195299

object_name: Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type


subject: PUBCHEM.COMPOUND:146195299

object_name: Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma


subject: PUBCHEM.COMPOUND:146195299

object_name: Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type


subject: PUBCHEM.COMPOUND:146195299

object_name: Refractory Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation


subject: PUBCHEM.COMPOUND:146195299

object_name: Recurrent Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation


subject: PUBCHEM.COMPOUND:146195299

object_name: Recurrent Grade 3b Follicular Lymphoma


subject: UNII:29HLR8Z5BR

subject_name: GOLCADOMIDE

object_name: Refractory Aggressive B-Cell Non-Hodgkin Lymphoma


subject: UNII:29HLR8Z5BR

object_name: Recurrent Aggressive B-Cell Non-Hodgkin Lymphoma


subject: UNII:29HLR8Z5BR

object_name: Refractory Transformed Non-Hodgkin Lymphoma


subject: UNII:29HLR8Z5BR

object_name: Non-Hodgkin's lymphoma transformed recurrent


subject: UNII:29HLR8Z5BR

object_name: Refractory ALK-Positive Large B-Cell Lymphoma


subject: UNII:29HLR8Z5BR

object_name: Refractory Intravascular Large B-Cell Lymphoma


subject: UNII:29HLR8Z5BR

object_name: Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type


subject: UNII:29HLR8Z5BR

object_name: Large B-cell lymphoma with IRF4 rearrangement


subject: UNII:29HLR8Z5BR

object_name: Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma


subject: UNII:29HLR8Z5BR

object_name: Refractory High Grade B-Cell Lymphoma, Not Otherwise Specified


subject: UNII:29HLR8Z5BR

object_name: Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: UNII:29HLR8Z5BR

object_name: Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type


subject: UNII:29HLR8Z5BR

object_name: Refractory Grade 3b Follicular Lymphoma


subject: UNII:29HLR8Z5BR

object_name: Primary mediastinal large B-cell lymphoma recurrent


subject: UNII:29HLR8Z5BR

object_name: Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified


subject: UNII:29HLR8Z5BR

object_name: Refractory Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type


subject: UNII:29HLR8Z5BR

object_name: Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: UNII:29HLR8Z5BR

object_name: Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: UNII:29HLR8Z5BR

object_name: Recurrent ALK-Positive Large B-Cell Lymphoma


subject: UNII:29HLR8Z5BR

object_name: Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type


subject: UNII:29HLR8Z5BR

object_name: Recurrent Intravascular Large B-Cell Lymphoma


subject: UNII:29HLR8Z5BR

object_name: Recurrent EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: UNII:29HLR8Z5BR

object_name: Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type


subject: UNII:29HLR8Z5BR

object_name: Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma


subject: UNII:29HLR8Z5BR

object_name: Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type


subject: UNII:29HLR8Z5BR

object_name: Refractory Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation


subject: UNII:29HLR8Z5BR

object_name: Recurrent Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation


subject: UNII:29HLR8Z5BR

object_name: Recurrent Grade 3b Follicular Lymphoma


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Recurrent Aggressive B-Cell Non-Hodgkin Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Refractory ALK-Positive Large B-Cell Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Refractory Intravascular Large B-Cell Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type


subject: UNII:4F4X42SYQ6

object_name: Large B-cell lymphoma with IRF4 rearrangement


subject: UNII:4F4X42SYQ6

object_name: Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type


subject: UNII:4F4X42SYQ6

object_name: Refractory Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type


subject: UNII:4F4X42SYQ6

object_name: Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: UNII:4F4X42SYQ6

object_name: Recurrent ALK-Positive Large B-Cell Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type


subject: UNII:4F4X42SYQ6

object_name: Recurrent Intravascular Large B-Cell Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Recurrent EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: UNII:4F4X42SYQ6

object_name: Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type


subject: UNII:4F4X42SYQ6

object_name: Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type


subject: UNII:4F4X42SYQ6

object_name: Refractory Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation


subject: UNII:4F4X42SYQ6

object_name: Recurrent Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation


subject: UNII:4F4X42SYQ6

object_name: Recurrent Grade 3b Follicular Lymphoma


subject: UMLS:C0295415

subject_name: rituximab

object_name: Recurrent Aggressive B-Cell Non-Hodgkin Lymphoma


subject: UMLS:C0295415

object_name: Refractory ALK-Positive Large B-Cell Lymphoma


subject: UMLS:C0295415

object_name: Refractory Intravascular Large B-Cell Lymphoma


subject: UMLS:C0295415

object_name: Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type


subject: UMLS:C0295415

object_name: Large B-cell lymphoma with IRF4 rearrangement


subject: UMLS:C0295415

object_name: Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma


subject: UMLS:C0295415

object_name: Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type


subject: UMLS:C0295415

object_name: Refractory Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type


subject: UMLS:C0295415

object_name: Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: UMLS:C0295415

object_name: Recurrent ALK-Positive Large B-Cell Lymphoma


subject: UMLS:C0295415

object_name: Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type


subject: UMLS:C0295415

object_name: Recurrent Intravascular Large B-Cell Lymphoma


subject: UMLS:C0295415

object_name: Recurrent EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: UMLS:C0295415

object_name: Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type


subject: UMLS:C0295415

object_name: Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma


subject: UMLS:C0295415

object_name: Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type


subject: UMLS:C0295415

object_name: Refractory Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation


subject: UMLS:C0295415

object_name: Recurrent Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation


subject: UMLS:C0295415

object_name: Recurrent Grade 3b Follicular Lymphoma


subject: CHEBI:194186

subject_name: Tirzepatide

object_name: ulcerative colitis


subject: PUBCHEM.COMPOUND:78162481

subject_name: Lorlatinib

object_name: ALK gene mutation


subject: CHEBI:188562

subject_name: Tofimilast

object_name: asthma


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: brain edema


subject: UMLS:C0085155

subject_name: Generic Drugs


subject: CHEBI:5134

subject_name: Fluticasone

object_name: blepharitis


subject: CHEBI:27241

subject_name: methyl uridin-5-yloxyacetate

object_name: pancreatic neoplasm


subject: CHEBI:73616

subject_name: Met-Val


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Acne inversa


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: chronic hepatitis B virus infection


subject: CHEBI:85078

object_name: hepatitis B


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Amputated structure (morphologic abnormality)


subject: CHEBI:9460

subject_name: Testolactone

object_name: precocious puberty


subject: CHEBI:9460

object_name: Precocious Puberty, CTCAE 5.0


subject: CHEBI:9460

object_name: polyostotic fibrous dysplasia


subject: CHEBI:9460

object_name: McCune-Albright syndrome


subject: CHEBI:80343

subject_name: Mecasermin

object_name: Ehlers-Danlos syndrome, classic type


subject: GTOPDB:8267

subject_name: milatuzumab

object_name: plasmacytoma


subject: UNII:2OP4E0GC6V


subject: UMLS:C2716103


subject: UMLS:C2958908

subject_name: Injection, denosumab, 1 mg administered

object_name: osteoporosis


subject: UMLS:C5203422

subject_name: Denosumab Liquid Injection


subject: UNII:M3H4D91AY5

subject_name: Rencofilstat

object_name: NASH with fibrosis


subject: CHEBI:145304

subject_name: monoacylglycerol 22:5


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: malignant large intestine neoplasm stage IIIb


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIB Colon Cancer AJCC v8


subject: CHEBI:114785

subject_name: Erlotinib

object_name: stage IVA rectal cancer


subject: CHEBI:114785

object_name: Stage IVA Rectal Cancer AJCC v7


subject: CHEBI:114785

object_name: Stage IVA Rectal Cancer AJCC v8


subject: CHEBI:114785

object_name: Stage IVB Rectal Cancer AJCC v7


subject: CHEBI:114785

object_name: Stage IVB Rectal Cancer AJCC v8


subject: CHEBI:114785

object_name: stage IVB rectal cancer


subject: CHEBI:114785

object_name: stage IVB colon cancer


subject: CHEBI:114785

object_name: Stage IVB Colon Cancer AJCC v7


subject: CHEBI:114785

object_name: Stage IVB Colon Cancer AJCC v8


subject: CHEBI:114785

object_name: stage IVA colon cancer


subject: CHEBI:114785

object_name: Stage IVA Colon Cancer AJCC v7


subject: CHEBI:114785

object_name: Stage IVA Colon Cancer AJCC v8


subject: CHEBI:114785

object_name: colon signet ring cell adenocarcinoma


subject: CHEBI:114785

object_name: colon mucinous adenocarcinoma


subject: CHEBI:114785

object_name: rectal signet ring cell adenocarcinoma


subject: CHEBI:114785

object_name: rectum mucinous adenocarcinoma


subject: UMLS:C4688012

subject_name: Anti-NaPi2b/Auristatin F-HPA ADC XMT-1536

object_name: lung adenocarcinoma


subject: UNII:9566855ULN

subject_name: ISOBUTAMBEN

object_name: Neuromuscular inhibition


subject: UNII:9566855ULN

object_name: Neuromuscular block, function


subject: CHEBI:6759

subject_name: Mepivacaine


subject: CHEBI:6759


subject: UNII:J1I0P6WT7T

subject_name: Verubecestat

object_name: Alzheimer disease


subject: CHEBI:16113

subject_name: Cholesterol

object_name: type 2 diabetes mellitus


subject: CHEBI:16113

object_name: Diabetes


subject: CHEBI:16113

object_name: diabetes mellitus


subject: CHEBI:16113

object_name: cardiovascular disorder


subject: CHEBI:16113

object_name: carotid atherosclerosis


subject: CHEBI:16113

object_name: hypertension


subject: CHEBI:16113

object_name: Hypertension, CTCAE


subject: CHEBI:16113

object_name: hyperlipidemia


subject: CHEBI:16113

object_name: hyperlipoproteinemia


subject: CHEBI:16113

object_name: Hyperlipidemia, CTCAE


subject: CHEBI:16113

object_name: Serum lipids high (finding)


subject: CHEBI:28241

subject_name: Papaverine

object_name: non-small cell lung carcinoma


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: metabolic bone disorder


subject: UMLS:C1530450

subject_name: AMG 162


subject: CHEBI:6754

subject_name: Meperidine

object_name: outcomes general quality of life


subject: CHEBI:6754

object_name: Perceived quality of life


subject: CHEBI:6754

object_name: Good quality of life


subject: UNII:FPI2G03BJ1

object_name: Atopic rhinitis


subject: UNII:FPI2G03BJ1

object_name: Allergic Rhinitis, CTCAE


subject: CHEBI:63959

subject_name: Celastrol

object_name: Safety Issues


subject: CHEBI:231342

subject_name: ceralasertib

object_name: small cell carcinoma


subject: CHEBI:231342

object_name: small cell lung carcinoma


subject: UMLS:C3827158


subject: UMLS:C3827158


subject: UMLS:C1610414

subject_name: R-roscovitine

object_name: Cushing Disease


subject: UMLS:C4079422

subject_name: AMG 139

object_name: psoriasis


subject: CHEBI:17858

subject_name: oxiglutatione

object_name: liver cirrhosis


subject: CHEBI:17858

object_name: liver cancer


subject: CHEBI:17858

object_name: liver neoplasm


subject: CHEBI:17858

object_name: Adult Liver Carcinoma


subject: CHEBI:17858

object_name: liver carcinoma


subject: CHEBI:177535

subject_name: L-Glutathione (reduced)


subject: CHEBI:177535


subject: CHEBI:177535


subject: CHEBI:177535


subject: CHEBI:177535


subject: CHEBI:57925


subject: CHEBI:57925


subject: CHEBI:57925


subject: CHEBI:57925


subject: CHEBI:57925


subject: CHEBI:177258

subject_name: Cytidine 2',3'-cyclic phosphate


subject: CHEBI:177258


subject: CHEBI:177258


subject: CHEBI:177258


subject: CHEBI:177258


subject: CHEBI:16856

subject_name: Glutathione


subject: CHEBI:16856


subject: CHEBI:16856


subject: CHEBI:16856


subject: CHEBI:16856


subject: CHEBI:27306

subject_name: vitamin B6


subject: CHEBI:27306


subject: CHEBI:27306


subject: CHEBI:27306


subject: CHEBI:27374

subject_name: Levoinositol

object_name: type 1 diabetes mellitus


subject: CHEBI:27372


subject: GTOPDB:12989

subject_name: toripalimab

object_name: malignant tumor of nasopharynx


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C2346514

subject_name: Intranasal Ketamine

object_name: Sedation


subject: UMLS:C2346514

object_name: Sedated


subject: CHEBI:8802

subject_name: Remifentanil

object_name: inhalation of nitrous oxide


subject: CHEBI:8802

object_name: cesarean section; complications


subject: MESH:C576360

object_name: age-related macular degeneration


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: Alzheimer disease


subject: PUBCHEM.COMPOUND:54675783

object_name: mild neurocognitive disorder


subject: PUBCHEM.COMPOUND:54675783

object_name: mild cognitive impairment


subject: PUBCHEM.COMPOUND:64145

subject_name: Labradimil

object_name: brain cancer


subject: PUBCHEM.COMPOUND:64145

object_name: brain neoplasm


subject: PUBCHEM.COMPOUND:64145

object_name: medulloblastoma


subject: PUBCHEM.COMPOUND:64145

object_name: childhood medulloblastoma


subject: PUBCHEM.COMPOUND:64145

object_name: adult medulloblastoma


subject: PUBCHEM.COMPOUND:64145

object_name: glioma


subject: PUBCHEM.COMPOUND:64145

object_name: malignant glioma


subject: UMLS:C0289630


subject: UMLS:C0289630


subject: UMLS:C0289630


subject: UMLS:C0289630


subject: UMLS:C0289630


subject: UMLS:C0289630


subject: UMLS:C0289630


subject: CHEBI:31684

subject_name: Ibudilast

object_name: primary progressive multiple sclerosis


subject: CHEBI:31684

object_name: secondary progressive multiple sclerosis


subject: UNII:CEGM9YBNGD

subject_name: Selpercatinib

object_name: Recurrent Lymphoma


subject: UNII:CEGM9YBNGD

object_name: Refractory Lymphoma


subject: UNII:CEGM9YBNGD

object_name: Recurrent Histiocytic and Dendritic Cell Neoplasm


subject: UNII:CEGM9YBNGD

object_name: Refractory Histiocytic and Dendritic Cell Neoplasm


subject: UNII:CEGM9YBNGD

object_name: hematopoietic and lymphoid system neoplasm


subject: UNII:CEGM9YBNGD

object_name: Refractory Soft Tissue Sarcoma


subject: UNII:CEGM9YBNGD

object_name: Recurrent Malignant Glioma


subject: UNII:CEGM9YBNGD

object_name: Refractory Malignant Glioma


subject: UNII:CEGM9YBNGD

object_name: Recurrent WHO Grade 2 Glioma


subject: UNII:CEGM9YBNGD

object_name: Recurrent Rhabdomyosarcoma


subject: UNII:CEGM9YBNGD

object_name: Refractory WHO Grade 2 Glioma


subject: UNII:CEGM9YBNGD

object_name: Refractory Ependymoma


subject: CHEBI:193615

object_name: Cross Infection


subject: UMLS:C0947603

subject_name: FUDR brand of floxuridine


subject: CHEBI:60761

subject_name: Floxuridine


subject: CHEBI:6067

subject_name: Isotretinoin

object_name: Refractory Neuroblastoma


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Neuroblastoma recurrent


subject: CHEBI:63791


subject: CHEBI:16586

subject_name: Aminocaproic acid

object_name: Oral bleeding


subject: CHEBI:16586

object_name: Oral Hemorrhage, CTCAE


subject: UMLS:C0002546

subject_name: Aminocaproic Acids


subject: UMLS:C0002546


subject: UNII:XX2MN88N5D

subject_name: Efalizumab

object_name: rheumatoid arthritis


subject: CHEBI:15342

subject_name: acenaphthoquinone

object_name: malaria


subject: CHEBI:73788

subject_name: Ala-Gln


subject: UMLS:C0135615

subject_name: Proprotein Convertase 1

object_name: prostate carcinoma


subject: UMLS:C0135615

object_name: prostate cancer


subject: PR:000012433

subject_name: neuroendocrine convertase 1


subject: PR:000012433


subject: PR:000005089

subject_name: chromobox protein homolog 8


subject: PR:000005089


subject: PR:000004845

subject_name: protein BTG2


subject: PR:000004845


subject: UMLS:C1518386

subject_name: Non-Steroidal Aromatase Inhibitor

object_name: Breast neoplasm female


subject: UMLS:C3827032

subject_name: Catequentinib Hydrochloride

object_name: metastatic pheochromocytoma


subject: UMLS:C3827032

object_name: Malignant Paraganglioma


subject: UMLS:C3827032

object_name: paragangliomas 1


subject: UMLS:C3827032

object_name: malignant adrenal gland pheochromocytoma


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: skin melanoma


subject: UMLS:C3827082


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: aggressive NK-cell leukemia


subject: UMLS:C1832035


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: NK-cell lymphoma


subject: CHEBI:41879


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:8382

subject_name: Prednisone


subject: UNII:T9FVH03HMZ

subject_name: Calaspargase pegol


subject: UNII:T9FVH03HMZ


subject: CHEBI:60789

subject_name: bupivacaine hydrochloride hydrate

object_name: Fractured forearm bone


subject: CHEBI:60789

object_name: Fractured ulna


subject: CHEBI:60789

object_name: radius fracture


subject: CHEBI:3215

subject_name: Bupivacaine


subject: CHEBI:3215


subject: CHEBI:6121

subject_name: Ketamine


subject: CHEBI:6121


subject: CHEBI:6121


subject: CHEBI:50847

subject_name: immunological adjuvant

object_name: Neck Carcinoma


subject: CHEBI:50847

object_name: head and neck neoplasm


subject: CHEBI:50847

object_name: head and neck cancer


subject: UMLS:C3641169

object_name: liver carcinoma


subject: MESH:D012900

subject_name: Smallpox Vaccine

object_name: vaccinia


subject: MESH:D012900

object_name: viral disease


subject: UMLS:C5703650

subject_name: Mpox Vaccine


subject: UMLS:C5703650


subject: CHEBI:64816

object_name: Stage III Breast Cancer AJCC v7


subject: CHEBI:64816

object_name: Stage III Breast Cancer AJCC v6


subject: PUBCHEM.COMPOUND:25136944

subject_name: Navelbine

object_name: Breast cancer stage II


subject: PUBCHEM.COMPOUND:25136944

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:25136944

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:25136944

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:25136944


subject: PUBCHEM.COMPOUND:25136944

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:25136944

object_name: Breast cancer stage III


subject: PUBCHEM.COMPOUND:25136944


subject: PUBCHEM.COMPOUND:25136944

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: UNII:G8RGG88B68

subject_name: Peginterferon alfa-2b

object_name: fallopian tube carcinoma


subject: UNII:G8RGG88B68

object_name: fallopian tube cancer


subject: UNII:G8RGG88B68

object_name: ovarian cancer


subject: UNII:G8RGG88B68

object_name: ovarian neoplasm


subject: UNII:G8RGG88B68

object_name: ovarian carcinoma


subject: UNII:G8RGG88B68

object_name: peritoneum cancer


subject: UNII:43K1W2T1M6

subject_name: Interferon alfa-2b

object_name: Genotype 3


subject: UMLS:C0021735

subject_name: Viraferon


subject: CHEBI:94463


subject: CHEBI:63580

subject_name: Ribavirin


subject: UMLS:C0021745

subject_name: interferon type II

object_name: hepatitis C


subject: UMLS:C0021745


subject: UMLS:C3539881

subject_name: gamma-interferon


subject: UMLS:C3539881


subject: PUBCHEM.COMPOUND:85364156

object_name: Parkinson disease


subject: UMLS:C3886758


subject: UNII:3X8387Q25N

object_name: Pseudopelade


subject: UNII:3X8387Q25N

object_name: Scarring alopecia of scalp


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: lung disorder


subject: CHEBI:4026

object_name: pulmonary fibrosis


subject: CHEBI:4026

object_name: Pulmonary Fibrosis, CTCAE


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:28838

subject_name: Lutein

object_name: retinitis pigmentosa


subject: CHEBI:28838

object_name: retinitis pigmentosa 1


subject: UniProtKB:P19726

subject_name: CAPSA_BPT7 Major capsid protein (sprot)


subject: UniProtKB:P19726


subject: MESH:D002214

subject_name: Capsules


subject: MESH:D002214


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: acute leukemia


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:4636

subject_name: Diphenhydramine

object_name: Myelodysplasia


subject: CHEBI:4636


subject: CHEBI:4636

object_name: Hodgkin Disease


subject: CHEBI:28918

subject_name: Epinephrine


subject: CHEBI:28918


subject: CHEBI:28918

object_name: non-Hodgkin lymphoma


subject: CHEBI:28918


subject: CHEBI:28918

object_name: plasma cell myeloma


subject: UNII:QMS40680K6

subject_name: Palifermin


subject: CHEBI:85361

subject_name: tetramethylsilane


subject: CHEBI:134689

subject_name: Rucaparib

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Carcinoma breast stage IV


subject: CHEBI:85078

object_name: Her2-receptor negative breast cancer


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: vitamin D deficiency


subject: UMLS:C3536908

subject_name: Omega-3 Fatty Acid [EPC]


subject: PUBCHEM.COMPOUND:135423438

subject_name: Nintedanib

object_name: Ovarian clear cell carcinoma


subject: PUBCHEM.COMPOUND:135423438

object_name: ovarian clear cell cancer


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Tonsillar hemorrhage


subject: UMLS:C0010377

subject_name: Crotoxin

object_name: cancer


subject: UMLS:C0010377

object_name: neoplasm


subject: UMLS:C5550162

subject_name: Hyland's 4 Kids Cold 'n Cough

object_name: Upper Respiratory Infections


subject: UMLS:C5222001

subject_name: whey protein hydrolysate

object_name: Muscle damage


subject: CHEBI:84415

subject_name: acetyltaurine

object_name: cervical polyp


subject: PR:000014937

subject_name: Na(+)/citrate cotransporter


subject: CHEBI:3921

subject_name: Cromakalim

object_name: cluster headache syndrome


subject: CHEBI:6436

subject_name: Levcromakalim


subject: UMLS:C0244960


subject: UNII:87GA2N3I5K

subject_name: INTEGRIN BETA-3

object_name: fetal and neonatal alloimmune thrombocytopenia


subject: UNII:CWG62Q1VTB

subject_name: Sitravatinib

object_name: small cell lung carcinoma


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: necrosis


subject: CHEBI:6888

object_name: Necrotic Area Imaging Finding


subject: CHEBI:6888

object_name: Necrotic Change


subject: CHEBI:6888

object_name: Skin Necrosis


subject: CHEBI:6888

object_name: Steroid nephropathy


subject: CHEBI:6888

object_name: Peripapillary crescent


subject: CHEBI:6888

object_name: IgA nephropathy, susceptibility to, 1


subject: CHEBI:29007

subject_name: Ceftriaxone

object_name: marasmus


subject: CHEBI:29007

object_name: Antibiotic Resistance, Microbial


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE


subject: UNII:L500PR95QA


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:6909


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: NK/T-cell lymphoma, nasal and nasal-type


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:8382

subject_name: Prednisone


subject: MESH:C496822

subject_name: xuezhikang

object_name: inherited lipid metabolism disorder


subject: CHEBI:231891


subject: UMLS:C4287651

subject_name: Quadrivalent Inactivated Influenza Vaccine

object_name: Well adult


subject: UMLS:C4287651

object_name: hepatitis A


subject: UMLS:C4287651

object_name: typhoid fever


subject: UMLS:C0378248

subject_name: Typhim VI

object_name: influenza


subject: UMLS:C0378248


subject: UMLS:C0378248


subject: UMLS:C0378248


subject: UMLS:C4048571

subject_name: hepatitis A virus strain CR 326F antigen, inactivated


subject: UMLS:C4048571


subject: UMLS:C4048571


subject: UMLS:C4048571


subject: DRUGBANK:DB11050

subject_name: Typhoid Vaccine Live


subject: DRUGBANK:DB11050


subject: DRUGBANK:DB11050


subject: UMLS:C2830053

object_name: Solid Neoplasm


subject: CHEBI:93775

subject_name: Amethopterin

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:93775

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:68646

subject_name: REGORAFENIB


subject: CHEBI:68646


subject: CHEBI:68646

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:71464

subject_name: Palmidrol

object_name: glaucoma


subject: CHEBI:71464

object_name: Glaucoma, CTCAE


subject: CHEBI:17553


subject: CHEBI:17553


subject: UMLS:C1572795

subject_name: PEA Preparation


subject: UMLS:C1572795


subject: CHEBI:18397

subject_name: Phenethylamine


subject: CHEBI:18397


subject: DRUGBANK:DB10551

subject_name: Pea


subject: DRUGBANK:DB10551


subject: UMLS:C4289938

subject_name: Balanced Crystalloid Solution

object_name: acute pancreatitis


subject: CHEBI:8871

subject_name: Risperidone

object_name: learning disability


subject: CHEBI:8871

object_name: Child Behavior Disorders


subject: UMLS:C0915344

subject_name: serogroup C meningococcal conjugate vaccine

object_name: meningitis


subject: UMLS:C0304604

subject_name: Topical form corticosteroids

object_name: Acanthamoeba keratitis


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: drug dependence


subject: CHEBI:131174

subject_name: Navitoclax

object_name: Unresectable Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:6427057

subject_name: ivermectin

object_name: clinical syndromes


subject: CHEBI:6078

subject_name: Ivermectin


subject: CHEBI:8802

subject_name: Remifentanil

object_name: respiratory failure


subject: CHEBI:8802

object_name: bronchopulmonary dysplasia


subject: CHEBI:8802

object_name: Respiratory insufficiency


subject: UNII:8G6X94GNHO

subject_name: Diethylhomospermine

object_name: diarrhea


subject: UNII:8G6X94GNHO

object_name: rectal discharge diarrhea (physical finding)


subject: UNII:8G6X94GNHO

object_name: Diarrhea, CTCAE


subject: UNII:8G6X94GNHO

object_name: HIV infection


subject: CHEBI:134716

subject_name: Brexpiprazole

object_name: Manic Episode


subject: CHEBI:49040

subject_name: Ezetimibe

object_name: Acute Ischemic Stroke


subject: CHEBI:53766

subject_name: Acenocoumarol

object_name: Intracranial hemorrhage


subject: CHEBI:53766

object_name: atrial flutter


subject: CHEBI:53766

object_name: Atrial Flutter by ECG Finding


subject: CHEBI:53766

object_name: Atrial Flutter, CTCAE


subject: CHEBI:53766

object_name: Microhaemorrhage


subject: CHEBI:53766

object_name: Intracranial Hemorrhage, Hypertensive


subject: CHEBI:53766

object_name: Intraventricular hemorrhage


subject: CHEBI:53766

object_name: subarachnoid hemorrhage


subject: CHEBI:53766

object_name: brain small vessel disease 3


subject: CHEBI:53766

object_name: Subdural hemorrhage


subject: CHEBI:72296

subject_name: Apixaban


subject: CHEBI:72296


subject: CHEBI:72296


subject: CHEBI:72296


subject: CHEBI:72296


subject: CHEBI:72296


subject: CHEBI:70746

subject_name: Dabigatran etexilate


subject: CHEBI:70746


subject: CHEBI:70746


subject: CHEBI:70746


subject: CHEBI:70746


subject: CHEBI:70746


subject: CHEBI:70746


subject: CHEBI:70752

subject_name: Dabigatran


subject: CHEBI:70752


subject: CHEBI:70752


subject: CHEBI:70752


subject: CHEBI:70752


subject: CHEBI:70752


subject: CHEBI:70752


subject: CHEBI:85974

subject_name: edoxaban tosylate hydrate


subject: CHEBI:85974


subject: CHEBI:85974


subject: CHEBI:85974


subject: CHEBI:85974


subject: CHEBI:85974


subject: CHEBI:85974


subject: CHEBI:85974


subject: CHEBI:85974


subject: PUBCHEM.COMPOUND:11635624

subject_name: Edoxaban


subject: PUBCHEM.COMPOUND:11635624


subject: PUBCHEM.COMPOUND:11635624


subject: PUBCHEM.COMPOUND:11635624


subject: PUBCHEM.COMPOUND:11635624


subject: PUBCHEM.COMPOUND:11635624


subject: CHEBI:8066

subject_name: Phenindione

object_name: atrial fibrillation


subject: CHEBI:8066

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:8066

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:8066


subject: CHEBI:8066


subject: CHEBI:8066


subject: CHEBI:8066


subject: CHEBI:8066


subject: CHEBI:8066


subject: CHEBI:8066


subject: CHEBI:8066


subject: CHEBI:8066


subject: CHEBI:8066


subject: CHEBI:68579

subject_name: Rivaroxaban


subject: CHEBI:68579


subject: CHEBI:68579


subject: CHEBI:68579


subject: CHEBI:68579


subject: CHEBI:68579


subject: CHEBI:10033

subject_name: Warfarin


subject: CHEBI:10033


subject: CHEBI:10033


subject: CHEBI:10033


subject: CHEBI:10033


subject: CHEBI:10033


subject: CHEBI:10033


subject: CHEBI:10033


subject: CHEBI:10033


subject: CHEBI:10033


subject: UNII:9G6U5L461Q

subject_name: Icotinib

object_name: Stage IB Non-Small Cell Lung Carcinoma AJCC v7


subject: UNII:9G6U5L461Q

object_name: stage IB non-small cell lung cancer


subject: UNII:9G6U5L461Q

object_name: lung large cell carcinoma


subject: UNII:9G6U5L461Q

object_name: adenosquamous lung carcinoma


subject: UNII:9G6U5L461Q

object_name: bronchial neoplasm


subject: CHEBI:7640

subject_name: Nortriptyline

object_name: traumatic encephalopathy


subject: CHEBI:7640

object_name: Post-Traumatic Headache


subject: CHEBI:7640

object_name: concussion


subject: CHEBI:7640

object_name: Mild Traumatic Brain Injury


subject: UMLS:C5392712

object_name: liver failure


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Adult Anaplastic Oligodendroglioma


subject: PUBCHEM.COMPOUND:131769963

object_name: Adult Anaplastic Astrocytoma


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:63631

subject_name: Topiramate

object_name: eating disorder


subject: DRUGBANK:DB06063

object_name: polycystic liver disease 1


subject: DRUGBANK:DB06063

object_name: autosomal dominant polycystic liver disease


subject: PUBCHEM.COMPOUND:4739

subject_name: Vidarbine

object_name: Adult Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:4739

object_name: Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:4739

object_name: lymphoma, non-Hodgkin, familial


subject: PUBCHEM.COMPOUND:4739

object_name: Adult Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:4739

object_name: Childhood Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:4739

object_name: Waldenstrom macroglobulinemia


subject: PUBCHEM.COMPOUND:4739

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:229687


subject: CHEBI:229687


subject: CHEBI:229687


subject: CHEBI:229687


subject: CHEBI:229687


subject: CHEBI:229687


subject: CHEBI:229687


subject: CHEBI:27834

subject_name: Pentostatin


subject: CHEBI:27834


subject: CHEBI:27834


subject: CHEBI:27834


subject: CHEBI:27834


subject: CHEBI:27834


subject: CHEBI:27834


subject: UMLS:C5700219

subject_name: Therapeutic allogeneic lymphocytes

object_name: graft versus host disease


subject: UMLS:C5700219

object_name: acute lymphoblastic leukemia


subject: UMLS:C5700219


subject: UMLS:C5700219

object_name: acute myeloid leukemia


subject: UMLS:C5203530

subject_name: Tranexamic Acid Liquid Injection

object_name: Gastrointestinal hemorrhage


subject: CHEBI:3546

subject_name: Cepharanthine

object_name: Asymptomatic SARS-CoV-2


subject: UMLS:C5853669

object_name: Burn injury


subject: CHEBI:68584

subject_name: Ezogabine

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:68584

object_name: amyotrophic lateral sclerosis


subject: CHEBI:31859

subject_name: Modafinil

object_name: postpoliomyelitis syndrome


subject: CHEBI:72323

subject_name: Alogliptin

object_name: acute coronary syndrome


subject: CHEBI:3614

subject_name: Chlorhexidine

object_name: Disinfectant causing toxic effect


subject: CHEBI:185135

subject_name: Polyvidone


subject: CHEBI:8347

subject_name: Povidone-iodine


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: Diabetic foot ulcer


subject: CHEBI:81579

subject_name: Erythropoietin


subject: CHEBI:9150

subject_name: Simvastatin

object_name: Noonan syndrome


subject: CHEBI:9150

object_name: Noonan syndrome 1


subject: UMLS:C3886729

object_name: gout


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Effects of chemotherapy


subject: CHEBI:74947

subject_name: Thalidomide


subject: PUBCHEM.COMPOUND:23431961

subject_name: Sodium citrate

object_name: end stage renal failure


subject: PUBCHEM.COMPOUND:23431961

object_name: Chronic uremia


subject: CHEBI:31206

subject_name: Chloroaminium


subject: CHEBI:31206


subject: CHEBI:28938

subject_name: ammonium


subject: CHEBI:28938


subject: UMLS:C3177195

object_name: Atopic rhinitis


subject: UMLS:C3177195

object_name: Allergic Rhinitis, CTCAE


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: pulmonary edema


subject: CHEBI:192614

object_name: Submersion


subject: CHEBI:192614

object_name: diving (history)


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: UNII:L6WO34R9YG


subject: UNII:L6WO34R9YG


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: PUBCHEM.COMPOUND:131769997


subject: PUBCHEM.COMPOUND:131769997


subject: CHEBI:183660

subject_name: Acetildenafil


subject: CHEBI:183660


subject: CHEBI:183660


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: UNII:80X7B1F6NW


subject: UNII:80X7B1F6NW


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:9139


subject: CHEBI:9139


subject: DRUGBANK:DB17253

subject_name: Fimaporfin

object_name: head and neck neoplasm


subject: DRUGBANK:DB17253

object_name: skin neoplasm


subject: UMLS:C2981863

subject_name: Amphinex


subject: UMLS:C2981863


subject: PUBCHEM.COMPOUND:44177671


subject: PUBCHEM.COMPOUND:44177671


subject: UMLS:C4722360


subject: UMLS:C4722360


subject: CHEBI:3139

subject_name: bleomycin


subject: CHEBI:15377

subject_name: Water

object_name: periodontitis


subject: CHEBI:31550

subject_name: Patupilone

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Miller-Dieker lissencephaly syndrome


subject: PUBCHEM.COMPOUND:131769963

object_name: myoclonic dystonia 11


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: UMLS:C1174389

object_name: Myelodysplasia


subject: UMLS:C1174389


subject: UMLS:C1174389


subject: UMLS:C1174389

object_name: acute myeloid leukemia


subject: PUBCHEM.COMPOUND:165437864

object_name: Huntington disease


subject: PUBCHEM.COMPOUND:165437864

object_name: Irritability


subject: UNII:372X2P22UY


subject: UNII:372X2P22UY


subject: UMLS:C2826152

subject_name: fluorescein sodium injection

object_name: stage IB melanoma


subject: UMLS:C2826152

object_name: stage IIIC melanoma


subject: UMLS:C2826152

object_name: stage IIC melanoma


subject: UMLS:C2826152

object_name: Stage IIC Cutaneous Melanoma AJCC v6 and v7


subject: UMLS:C2826152

object_name: stage IIA melanoma


subject: UMLS:C2826152

object_name: Stage IIA Cutaneous Melanoma AJCC v6 and v7


subject: UMLS:C2826152

object_name: stage IIB melanoma


subject: UMLS:C2826152

object_name: stage IIIB melanoma


subject: UMLS:C2826152

object_name: stage IIIA melanoma


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: disorder of glutamine metabolism


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:18050

subject_name: L-Glutamine


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: endophthalmitis


subject: CHEBI:26710

object_name: Endophthalmitis, CTCAE


subject: CHEBI:8455

subject_name: Proguanil

object_name: HIV infection


subject: CHEBI:38940

subject_name: Sunitinib

object_name: Adult Diffuse Large Cell Lymphoma


subject: CHEBI:38940

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: UMLS:C1518041

subject_name: Luteinizing Hormone-releasing Hormone Agonist

object_name: Pain in female genitalia on intercourse


subject: UMLS:C1518041

object_name: Dyspareunia


subject: UMLS:C1518041

object_name: Dyspareunia, CTCAE


subject: UMLS:C1518041

object_name: Painful intercourse female


subject: UMLS:C1518041

object_name: Dysmenorrhea, CTCAE


subject: PUBCHEM.COMPOUND:541197

subject_name: Norethindrone acetate


subject: PUBCHEM.COMPOUND:541197


subject: PUBCHEM.COMPOUND:541197


subject: PUBCHEM.COMPOUND:541197


subject: PUBCHEM.COMPOUND:541197


subject: PUBCHEM.COMPOUND:541197

object_name: Dysmenorrhea


subject: CHEBI:7627

subject_name: Norethisterone


subject: CHEBI:7627


subject: CHEBI:7627


subject: CHEBI:7627


subject: UNII:HR4RD5RBJ6

subject_name: Dazucorilant

object_name: Hepatic impairment


subject: UNII:9980ST005G

subject_name: Litoxetine

object_name: Urinary incontinence


subject: UNII:9980ST005G

object_name: Urinary Incontinence, CTCAE 5.0


subject: CHEBI:2567

subject_name: Alendronic acid

object_name: periodontitis


subject: CHEBI:50730

subject_name: Montelukast

object_name: Sleep Apnea, CTCAE


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: Pain Relief


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:149504

object_name: IgA nephropathy, susceptibility to, 1


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:36791

subject_name: Escitalopram

object_name: somatoform disorder


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: metastatic pheochromocytoma


subject: CHEBI:79699

object_name: malignant adrenal gland pheochromocytoma


subject: CHEBI:79699

object_name: Recurrent Merkel Cell Carcinoma


subject: CHEBI:79699

object_name: stage IV Merkel cell carcinoma


subject: CHEBI:79699

object_name: stage III Merkel cell carcinoma


subject: CHEBI:79699

object_name: Small cell lung cancer recurrent


subject: CHEBI:79699

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:79699

object_name: Non-small cell lung cancer stage IIIA


subject: CHEBI:79699

object_name: Non-small cell lung cancer stage IIIB


subject: CHEBI:79699

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:79699

object_name: stage III cervical cancer


subject: CHEBI:79699

object_name: Stage III Cervical Cancer AJCC v6 and v7


subject: CHEBI:79699

object_name: Stage III Cervical Cancer AJCC v8


subject: CHEBI:79699

object_name: medullary thyroid gland carcinoma


subject: CHEBI:79699

object_name: Stage III Prostate Cancer AJCC v8


subject: CHEBI:79699

object_name: Stage III Prostate Cancer AJCC v7


subject: CHEBI:79699

object_name: Carcinoma of the prostate stage III


subject: CHEBI:79699

object_name: Stage III Prostate Cancer AJCC v6


subject: CHEBI:79699

object_name: recurrent pheochromocytoma


subject: CHEBI:79699

object_name: regional pheochromocytoma


subject: CHEBI:79699

object_name: Hereditary Paraganglioma


subject: CHEBI:79699

object_name: Stage III Uterine Sarcoma AJCC v7


subject: CHEBI:79699

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:79699

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:79699

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:79699

object_name: Stage IV Uterine Sarcoma AJCC v7


subject: CHEBI:79699

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:79699

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:79699

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:79699

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:79699

object_name: Carcinoma breast stage IV


subject: CHEBI:79699

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:79699

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:79699

object_name: Malignant Paraganglioma


subject: CHEBI:32296

subject_name: vinorelbine L-tartrate

object_name: metastatic pheochromocytoma


subject: CHEBI:32296

object_name: malignant adrenal gland pheochromocytoma


subject: CHEBI:32296

object_name: Metastatic Digestive System Neuroendocrine Tumor G1


subject: CHEBI:32296

object_name: metastatic gastrointestinal carcinoid tumor


subject: CHEBI:32296

object_name: PPoma


subject: CHEBI:32296

object_name: Recurrent Ovarian Germ Cell Tumor


subject: CHEBI:32296

object_name: Recurrent Merkel Cell Carcinoma


subject: CHEBI:32296

object_name: stage IV Merkel cell carcinoma


subject: CHEBI:32296

object_name: stage III Merkel cell carcinoma


subject: CHEBI:32296

object_name: Regional Digestive System Neuroendocrine Tumor G1


subject: CHEBI:32296

object_name: Recurrent Digestive System Neuroendocrine Tumor G1


subject: CHEBI:32296

object_name: Ovarian germ cell cancer stage IV


subject: CHEBI:32296

object_name: Stage IV Ovarian Germ Cell Tumor AJCC v6 and v7


subject: CHEBI:32296

object_name: Stage III Ovarian Germ Cell Tumor AJCC v6 and v7


subject: CHEBI:32296

object_name: Renal cell carcinoma recurrent


subject: CHEBI:32296

object_name: Renal cancer recurrent


subject: CHEBI:32296

object_name: Small cell lung cancer recurrent


subject: CHEBI:32296

object_name: recurrent islet cell carcinoma


subject: CHEBI:32296

object_name: Recurrent Endometrial Cancer


subject: CHEBI:32296

object_name: Small cell lung cancer extensive stage


subject: CHEBI:32296

object_name: Non-small cell lung cancer stage IIIA


subject: CHEBI:32296

object_name: Non-small cell lung cancer stage IIIB


subject: CHEBI:32296

object_name: Recurrent ovarian cancer


subject: CHEBI:32296

object_name: Stage III Renal Cell Cancer AJCC v8


subject: CHEBI:32296

object_name: Stage III renal cell cancer


subject: CHEBI:32296

object_name: Stage III Renal Cell Cancer AJCC v7


subject: CHEBI:32296

object_name: Stage IV Renal Cell Cancer


subject: CHEBI:32296

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:32296

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: CHEBI:32296

object_name: Prostate cancer recurrent


subject: CHEBI:32296

object_name: Endometrial cancer stage III


subject: CHEBI:32296

object_name: Metastatic Endometrial Carcinoma


subject: CHEBI:32296

object_name: Ovarian cancer stage III


subject: CHEBI:32296

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:32296

object_name: Ovarian cancer stage IV


subject: CHEBI:32296

object_name: Stage IVA Cervical Cancer AJCC v8


subject: CHEBI:32296

object_name: Stage IVA Cervical Cancer AJCC v6 and v7


subject: CHEBI:32296

object_name: Cervical carcinoma stage IVA


subject: CHEBI:32296

object_name: stage III cervical cancer


subject: CHEBI:32296

object_name: Stage III Cervical Cancer AJCC v6 and v7


subject: CHEBI:32296

object_name: Stage III Cervical Cancer AJCC v8


subject: CHEBI:32296

object_name: Recurrent Uterine Sarcoma


subject: CHEBI:32296

object_name: medullary thyroid gland carcinoma


subject: CHEBI:32296

object_name: Stage III Prostate Cancer AJCC v8


subject: CHEBI:32296

object_name: Stage III Prostate Cancer AJCC v7


subject: CHEBI:32296

object_name: Carcinoma of the prostate stage III


subject: CHEBI:32296

object_name: Stage III Prostate Cancer AJCC v6


subject: CHEBI:32296

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:32296

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:32296

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:32296

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:32296

object_name: recurrent pheochromocytoma


subject: CHEBI:32296

object_name: regional pheochromocytoma


subject: CHEBI:32296

object_name: Hereditary Paraganglioma


subject: CHEBI:32296

object_name: Stage III Uterine Sarcoma AJCC v7


subject: CHEBI:32296

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:32296

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:32296

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:32296

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:32296

object_name: Stage IV Uterine Sarcoma AJCC v7


subject: CHEBI:32296

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:32296

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:32296

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:32296

object_name: Malignant Paraganglioma


subject: CHEBI:53750

subject_name: vinorelbine D-tartrate

object_name: metastatic pheochromocytoma


subject: CHEBI:53750

object_name: malignant adrenal gland pheochromocytoma


subject: CHEBI:53750

object_name: Metastatic Digestive System Neuroendocrine Tumor G1


subject: CHEBI:53750

object_name: metastatic gastrointestinal carcinoid tumor


subject: CHEBI:53750

object_name: PPoma


subject: CHEBI:53750

object_name: Recurrent Ovarian Germ Cell Tumor


subject: CHEBI:53750

object_name: Recurrent Merkel Cell Carcinoma


subject: CHEBI:53750

object_name: stage IV Merkel cell carcinoma


subject: CHEBI:53750

object_name: stage III Merkel cell carcinoma


subject: CHEBI:53750

object_name: Regional Digestive System Neuroendocrine Tumor G1


subject: CHEBI:53750

object_name: Recurrent Digestive System Neuroendocrine Tumor G1


subject: CHEBI:53750

object_name: Ovarian germ cell cancer stage IV


subject: CHEBI:53750

object_name: Stage IV Ovarian Germ Cell Tumor AJCC v6 and v7


subject: CHEBI:53750

object_name: Stage III Ovarian Germ Cell Tumor AJCC v6 and v7


subject: CHEBI:53750

object_name: Renal cell carcinoma recurrent


subject: CHEBI:53750

object_name: Renal cancer recurrent


subject: CHEBI:53750

object_name: Small cell lung cancer recurrent


subject: CHEBI:53750

object_name: recurrent islet cell carcinoma


subject: CHEBI:53750

object_name: Recurrent Endometrial Cancer


subject: CHEBI:53750

object_name: Small cell lung cancer extensive stage


subject: CHEBI:53750

object_name: Non-small cell lung cancer stage IIIA


subject: CHEBI:53750

object_name: Non-small cell lung cancer stage IIIB


subject: CHEBI:53750

object_name: Recurrent ovarian cancer


subject: CHEBI:53750

object_name: Stage III Renal Cell Cancer AJCC v8


subject: CHEBI:53750

object_name: Stage III renal cell cancer


subject: CHEBI:53750

object_name: Stage III Renal Cell Cancer AJCC v7


subject: CHEBI:53750

object_name: Stage IV Renal Cell Cancer


subject: CHEBI:53750

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:53750

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: CHEBI:53750

object_name: Prostate cancer recurrent


subject: CHEBI:53750

object_name: Endometrial cancer stage III


subject: CHEBI:53750

object_name: Metastatic Endometrial Carcinoma


subject: CHEBI:53750

object_name: Ovarian cancer stage III


subject: CHEBI:53750

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:53750

object_name: Ovarian cancer stage IV


subject: CHEBI:53750

object_name: Stage IVA Cervical Cancer AJCC v8


subject: CHEBI:53750

object_name: Stage IVA Cervical Cancer AJCC v6 and v7


subject: CHEBI:53750

object_name: Cervical carcinoma stage IVA


subject: CHEBI:53750

object_name: stage III cervical cancer


subject: CHEBI:53750

object_name: Stage III Cervical Cancer AJCC v6 and v7


subject: CHEBI:53750

object_name: Stage III Cervical Cancer AJCC v8


subject: CHEBI:53750

object_name: Recurrent Uterine Sarcoma


subject: CHEBI:53750

object_name: medullary thyroid gland carcinoma


subject: CHEBI:53750

object_name: Stage III Prostate Cancer AJCC v8


subject: CHEBI:53750

object_name: Stage III Prostate Cancer AJCC v7


subject: CHEBI:53750

object_name: Carcinoma of the prostate stage III


subject: CHEBI:53750

object_name: Stage III Prostate Cancer AJCC v6


subject: CHEBI:53750

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:53750

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:53750

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:53750

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:53750

object_name: recurrent pheochromocytoma


subject: CHEBI:53750

object_name: regional pheochromocytoma


subject: CHEBI:53750

object_name: Hereditary Paraganglioma


subject: CHEBI:53750

object_name: Stage III Uterine Sarcoma AJCC v7


subject: CHEBI:53750

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:53750

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:53750

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:53750

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:53750

object_name: Stage IV Uterine Sarcoma AJCC v7


subject: CHEBI:53750

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:53750

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:53750

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:53750

object_name: Malignant Paraganglioma


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine

object_name: metastatic pheochromocytoma


subject: PUBCHEM.COMPOUND:44424639

object_name: malignant adrenal gland pheochromocytoma


subject: PUBCHEM.COMPOUND:44424639

object_name: Metastatic Digestive System Neuroendocrine Tumor G1


subject: PUBCHEM.COMPOUND:44424639

object_name: metastatic gastrointestinal carcinoid tumor


subject: PUBCHEM.COMPOUND:44424639

object_name: PPoma


subject: PUBCHEM.COMPOUND:44424639

object_name: Recurrent Ovarian Germ Cell Tumor


subject: PUBCHEM.COMPOUND:44424639

object_name: Recurrent Merkel Cell Carcinoma


subject: PUBCHEM.COMPOUND:44424639

object_name: stage IV Merkel cell carcinoma


subject: PUBCHEM.COMPOUND:44424639

object_name: stage III Merkel cell carcinoma


subject: PUBCHEM.COMPOUND:44424639

object_name: Regional Digestive System Neuroendocrine Tumor G1


subject: PUBCHEM.COMPOUND:44424639

object_name: Recurrent Digestive System Neuroendocrine Tumor G1


subject: PUBCHEM.COMPOUND:44424639

object_name: Ovarian germ cell cancer stage IV


subject: PUBCHEM.COMPOUND:44424639

object_name: Stage IV Ovarian Germ Cell Tumor AJCC v6 and v7


subject: PUBCHEM.COMPOUND:44424639

object_name: Stage III Ovarian Germ Cell Tumor AJCC v6 and v7


subject: PUBCHEM.COMPOUND:44424639

object_name: Renal cell carcinoma recurrent


subject: PUBCHEM.COMPOUND:44424639

object_name: Renal cancer recurrent


subject: PUBCHEM.COMPOUND:44424639

object_name: Small cell lung cancer recurrent


subject: PUBCHEM.COMPOUND:44424639

object_name: recurrent islet cell carcinoma


subject: PUBCHEM.COMPOUND:44424639

object_name: Recurrent Endometrial Cancer


subject: PUBCHEM.COMPOUND:44424639

object_name: Small cell lung cancer extensive stage


subject: PUBCHEM.COMPOUND:44424639

object_name: Non-small cell lung cancer stage IIIA


subject: PUBCHEM.COMPOUND:44424639

object_name: Stage III Renal Cell Cancer AJCC v8


subject: PUBCHEM.COMPOUND:44424639

object_name: Stage III renal cell cancer


subject: PUBCHEM.COMPOUND:44424639

object_name: Stage III Renal Cell Cancer AJCC v7


subject: PUBCHEM.COMPOUND:44424639

object_name: Stage IV Renal Cell Cancer


subject: PUBCHEM.COMPOUND:44424639

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: PUBCHEM.COMPOUND:44424639

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: PUBCHEM.COMPOUND:44424639

object_name: Endometrial cancer stage III


subject: PUBCHEM.COMPOUND:44424639

object_name: Metastatic Endometrial Carcinoma


subject: PUBCHEM.COMPOUND:44424639

object_name: Ovarian cancer stage III


subject: PUBCHEM.COMPOUND:44424639

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:44424639

object_name: Ovarian cancer stage IV


subject: PUBCHEM.COMPOUND:44424639

object_name: Stage IVA Cervical Cancer AJCC v8


subject: PUBCHEM.COMPOUND:44424639

object_name: Stage IVA Cervical Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:44424639

object_name: Cervical carcinoma stage IVA


subject: PUBCHEM.COMPOUND:44424639

object_name: stage III cervical cancer


subject: PUBCHEM.COMPOUND:44424639

object_name: Stage III Cervical Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:44424639

object_name: Stage III Cervical Cancer AJCC v8


subject: PUBCHEM.COMPOUND:44424639

object_name: Recurrent Uterine Sarcoma


subject: PUBCHEM.COMPOUND:44424639

object_name: medullary thyroid gland carcinoma


subject: PUBCHEM.COMPOUND:44424639

object_name: Stage III Prostate Cancer AJCC v8


subject: PUBCHEM.COMPOUND:44424639

object_name: Stage III Prostate Cancer AJCC v7


subject: PUBCHEM.COMPOUND:44424639

object_name: Carcinoma of the prostate stage III


subject: PUBCHEM.COMPOUND:44424639

object_name: Stage III Prostate Cancer AJCC v6


subject: PUBCHEM.COMPOUND:44424639

object_name: Stage IV Prostate Cancer AJCC v6


subject: PUBCHEM.COMPOUND:44424639

object_name: Carcinoma of the prostate stage IV


subject: PUBCHEM.COMPOUND:44424639

object_name: Stage IV Prostate Cancer AJCC v7


subject: PUBCHEM.COMPOUND:44424639

object_name: Stage IV Prostate Cancer AJCC v8


subject: PUBCHEM.COMPOUND:44424639

object_name: recurrent pheochromocytoma


subject: PUBCHEM.COMPOUND:44424639

object_name: regional pheochromocytoma


subject: PUBCHEM.COMPOUND:44424639

object_name: Hereditary Paraganglioma


subject: PUBCHEM.COMPOUND:44424639

object_name: Stage III Uterine Sarcoma AJCC v7


subject: PUBCHEM.COMPOUND:44424639

object_name: Stage IIIC Breast Cancer AJCC v6


subject: PUBCHEM.COMPOUND:44424639

object_name: Stage IIIC Breast Cancer AJCC v7


subject: PUBCHEM.COMPOUND:44424639

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:44424639

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8